ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Multiple sclerosis

Multiple sclerosis

Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.

©Tewan Banditrukkanka/Shutterstock.com

Can the EEG predict neurological outcomes in post-anoxic encephalopathy from out-of-hospital cardiac arrest? What effect does TIA have on stroke risk in women migraineurs? What's the relationship between MS and vitamin D levels in minority populations?

A switch to a second-line drug in a patient receiving first-line therapies likely will be effective at decreasing disease activity.

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Do you have a patient with "radiologically isolated syndrome" -- and, if so, what do you tell your patient?

Highlights of recent findings about multiple sclerosis are summarized in this slide show.

An FDA-approved drug for high blood pressure alleviates clinical symptoms of MS in mice, showing great promise for humans.

Pages

Subscribe to Multiple sclerosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.